Investor Summary: JOEY NEW YORK® (OTC – JOEY)

Joey New York is divided into two divisions. One being “THE LABB”, Aesthetic Beauty Bar. The other is the Joey New York® cosmetics. There is a high degree of synergy between the Cosmetic line and the LABB services.

With the decades of skincare experience that the team at Joey have, it is only logical that they leverage their experience by employing a new concept in the injectables market, (Botox® and Fillers). It's a concept called The LABB (Labb Aesthetic Beauty Bar). The LABB is focused on eliminating unwanted wrinkles by exclusively performing Botox® and filler injections, nothing else, no facials, no laser, just Botox® and fillers. This is a large segment of a 13-Billion-dollar market that has grown 6,400% since 1997. The concept is pretty simple. Excellent technicians, standardized training, multiple locations, consistent branding, incredibly low overhead and state of the art facilities with bulk buying purchasing power. With more people searching for a youthful look, Joey New York intends to lead them to it.

FINANCIAL PROJECTIONS

Year ends 2/29

2017 2018 2019 2020 2021

Revenue $ 12,148,113 $ 40,183,936 $ 80,367,872 $ 118,951,808 $ 157,535,744

SG&A and COS $ 7,067,184 $ 22,830,400 $ 45,660,800 $ 67,456,200 $ 89,251,600

Net Profit $ 5,080,929 $ 17,353,536 $ 34,707,072 $ 51,495,608 $ 68,284,144

Outstanding shares 27,862,019 32,000,000 37,000,000 42,000,000 49,000,000

Earnings per share $ 0.18 $ 0.54 $ 0.94 $ 1.23 $ 1.39

THE LABB:

• The mission of “The LABB” is to deliver the most exceptional client experience and results of beauty enhancement through the use of cutting edge science, technology and aesthetic craftsmanship from a most convenient platform. The LABB is poised to become the foremost leader in aesthetic service delivery by providing high quality injectables, utilizing the most advanced available technologies, tailored to each patient’s needs at an affordable price. By performing injectables exclusively, The LABB can streamline purchasing power, driving down the cost, making The LABB an attractive option to visiting a much more expensive cosmetic surgeon.

• The South Eastern costal market represents the 2nd largest injectable filler market in the U.S. (barely below California). This year there are 10 facilities identified to be opened, giving $5M in profit in the first 12 months. Next year they plan to roll out another 5 facilities. This will total 15 facilities yielding over $35M in profit. The pilot location has been opened in South Beach-Miami. This location is consistently fully booked out with a wait list. in July, a second Florida location opened in Daytona Beach, as well as a third location opened in Ft Lauderdale, both “soft opened” and are cash flow positive with growing customer bases. Additional Florida LABB’s are have been identified for Boca Raton, West Palm Beach, Aventura as well as other cities. Negotiations are already underway for LABB’s in California and Las Vegas.

Value Added

• Expertise and ability to combine medical and retail: Complete package that combines medical and retail in such a way that will capitalize and become a powerhouse, dominating the aesthetic beauty industry.

• Depth of knowledge of the markets and direct to consumer: Two entities joining together to create the said powerhouse dubbed The LABB. One entity bringing the depth of both medical and retail knowledge and the other with a large scope of both retail and direct to consumer know how which translates into money.

• Minimize risk and optimize safety: Being able to safely provide our products and services by having an OSHA consultant, HC Lawyer, RM consultant. Separating the Facility medical and purchasing account MD. Having insurance - general liability / premise coverage =1mil. Our NP’s have 250/750 malpractice "self employed aesthetics”. By having Safety & Compliance protocols with routine Quality Control Evaluations.

• Product purchasing power & reduced pricing: Because we have such a large purchasing account, we are able to drive down the purchasing cost to us.

• Original Model Scheme: The only model on the market to date that focuses on one objective and is able to capitalize on the clients through a non traditional medical model, rather focusing on a ”need” or “must have”

retail platform. By doing this we are creating a demand/supply for the aesthetic injecting market.

• Headquarters Location• Trump Tower 1• 16001 Collins Avenue, Su

3202• Sunny Isles Beach, FL 33160• www.joeynewyork.com• Symbol: OTC JOEY• Key Management• Joey Chancis, Founder/CEO• Richard Roer, President

Cosmetic Company Overview:

Founded by renowned skincare expert Joey Chancis over two decades ago, sold and recently repurchased, Joey New York® is beginning re-launched as a public company. Joey New York® has long been considered an innovative leader in the luxury skin care industry. Now, Joey returns with a focus on creating “world-class” beauty products that are highly effective and affordable. These products deliver instant visible results to an ever-expanding “health-conscious” consumer market that is constantly demanding healthy alternatives in everyday life. These products will be exclusively sold at all LABB locations. The products are specifically tailored to the needs of LABB clientele.

The company expects to be profitable by FY 2016 with accelerated growth in 2017 with expected revenue of more than $12M on gross margins over 60% and net margins exceeding 30%. Although forward-looking, recurring revenue from acquisition and private label branding would increase the company’s margins even more significantly.

Joey New York® Overview

• Joey New York® currently has a proven collection, called Instant Results, with a strategy of having a strong high-end retail presence in prestigious department and specialty stores such as Sephora, Nordstrom, Macy’s, Belk, Dillard’s, Ulta, independent boutiques and boutique chains throughout the U.S. and International Marketplace. Currently, Joey’s products can be found in Look boutiques, Peninsula beauty stores, as well as, online at Urban Outfitters and dermstore.com.

• Joey is preparing new collections: These products will be exclusively sold at all LABB locations. The products will be designed to enhance, and protect the customers LABB investment.

CURRENT AND PROJECTED PERFORMANCE:

• The company expects to be profitable by the end of 2016 with accelerated growth in 2017 with expected revenue of more than $5M.

• Future expectation of earnings beyond 2017, driven by increased consumer demand for healthy skin care products, is expected to be more than $9M on gross margins nearing 50% and net margins above 11%, on par with industry standards.

DISCLAIMER

• The financial information included in this presentation is preliminary, unaudited and subject to revision upon completion of the Company's closing and audit processes. This financial information has not been adjusted to reflect the outcome of any reorganization of the company’s capital structure, the resolution or impairment of any pre‐petition obligations, and does not reflect fresh start accounting which the company may be required to adopt. All forward–looking statements attributable to the Company or persons acting on its behalf apply only as of the date of this document, and are expressly qualified in their entirety by the cautionary statements included elsewhere in this document. The financial projections are preliminary and subject to change; the Company undertakes no obligation to update or revise these forward–looking statements to reflect events or circumstances that arise after the date made or to reflect the occurrence of unanticipated events. Inevitably, some assumptions will not materialize, and unanticipated events and circumstances may affect the ultimate financial results. Projections are inherently subject to substantial and numerous uncertainties and to a wide variety of significant business, economic and competitive risks, and the assumptions underlying the projections may be inaccurate in any material respect. Therefore, the actual results achieved may vary significantly from the forecasts, and the variations may be material.